ConductScience.org, home

Paper39145348

Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk.

Davies C and 12 others. Schizophr Bull Open, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk. Papers, record 39145348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39145348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk.
PubMed
Journal
Schizophr Bull Open
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.57
iCite
Revised in PubMed
2025-05-30
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davies CCathyhttps://orcid.org/0000-0003-3011-8643
2Bossong MGMatthijs G
3Martins DDaniel
4Wilson RRobin
5Appiah-Kusi EElizabethhttps://orcid.org/0000-0003-4249-5091
6Blest-Hopley GGrace
7Allen PPaul
8Zelaya FFernando
9Lythgoe DJDavid J
10Brammer MMichael
11Perez JJesus
12McGuire PPhilip
13Bhattacharyya SSagnik

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/J012149/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References83

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132159746Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.JAMA Psychiatry2020https://conductscience.org/library/papers/32159746PubMed
231771861Hippocampal Pathology in Clinical High-Risk Patients and the Onset of Schizophrenia.Biol Psychiatry2020https://conductscience.org/library/papers/31771861PubMed
321536967Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis.Arch Gen Psychiatry2011https://conductscience.org/library/papers/21536967PubMed
431681029Pan-London Network for Psychosis-Prevention (PNP).Front Psychiatry2019https://conductscience.org/library/papers/31681029PubMed
536696108Why Hippocampal Glutamate Levels Are Elevated in Schizophrenia.JAMA Psychiatry2023https://conductscience.org/library/papers/36696108PubMed
633414100The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol.Biol Psychiatry Cogn Neurosci Neuroimaging2021https://conductscience.org/library/papers/33414100PubMed
728115738Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum.Mol Psychiatry2017https://conductscience.org/library/papers/28115738PubMed
819349314Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.Arch Gen Psychiatry2009https://conductscience.org/library/papers/19349314PubMed
926970363Human Laboratory Studies on Cannabinoids and Psychosis.Biol Psychiatry2016https://conductscience.org/library/papers/26970363PubMed
1022213786Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.Arch Gen Psychiatry2012https://conductscience.org/library/papers/22213786PubMed
1131618752Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study.Neuropsychopharmacology2020https://conductscience.org/library/papers/31618752PubMed
1232921544Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.Eur Neuropsychopharmacol2020https://conductscience.org/library/papers/32921544PubMed
1326568030Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.Psychol Med2016https://conductscience.org/library/papers/26568030PubMed
1434584230Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.Mol Psychiatry2022https://conductscience.org/library/papers/34584230PubMed
1532848931Neurovascular Uncoupling in Schizophrenia: A Bimodal Meta-Analysis of Brain Perfusion and Glucose Metabolism.Front Psychiatry2020https://conductscience.org/library/papers/32848931PubMed
1621307846Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.Neuropsychopharmacology2011https://conductscience.org/library/papers/21307846PubMed
1734505389Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls.World Psychiatry2021https://conductscience.org/library/papers/34505389PubMed
1833941857Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes.Neuropsychopharmacology2021https://conductscience.org/library/papers/33941857PubMed
1930167644Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial.JAMA Psychiatry2018https://conductscience.org/library/papers/30167644PubMed
2020638047Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis.Biol Psychiatry2010https://conductscience.org/library/papers/20638047PubMed

See all 83 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
40259403Effect of cannabinoids on glutamate levels in the human brain: a systematic review and meta-analysis.J Cannabis Res2025https://conductscience.org/library/papers/40259403

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39145348

GET https://conductscience.org/api/papers/v1/39145348/references?page=2